Name
GLP-1s, Gene Therapies & the New Math of Affordability
Time
9:50 AM - 10:35 AM
Description

This session unpacks the financial and clinical pressures of covering today’s high-cost therapies, from GLP-1s to gene therapies. Learn how employers are managing demand, balancing access with cost, and preparing for the next wave of specialty drug approvals.

Ashley Hume Kirby Eng, RPh Jonathan Koval, PharmD, MBA Eileen Pincay, RPh